27335087|t|Fuzheng Qingjie Granules Inhibit Growth of Hepatoma Cells via Inducing Mitochondria -Mediated Apoptosis and Enhancing Immune Function
27335087|a|Fuzheng Qingjie (FZQJ) granules, a compound Chinese medicine, have been used as an adjuvant therapy for alimentary tract cancers. However, the underlying anticancer mechanisms are still not well understood. In the present study, HepG2 cells were treated with FZQJ - containing serum. Cell proliferation was evaluated using MTT assay. Apoptosis was analyzed using a flow cytometer. Cell ultrastructure was observed under a transmission electron microscope. The mitochondrial membrane potential (Δψ) was examined with JC-1 dye. In H22 tumor-bearing mice, CD4(+) T cells, CD8(+) T cells, CD3(+) T cells, and natural killer cells (NK) in peripheral blood were evaluated cytometrically. Interleukin (IL)-2 and tumor necrosis factor (TNF)-α levels were measured using radioimmunoassay .The mRNA levels of Bax and Bcl-2 were examined by reverse transcription-polymerase chain reaction. The protein levels of Bax, Bcl-2, cytochrome C, caspase 3 and 9, PARP, and CD69 were examined by Western blotting. The apoptotic cells in tissues were observed using TUNEL method. Alanine transaminase (ALT), aspartate transaminase (AST), blood urea nitrogen (BUN), and creatinine (CRE) were detected by an automatic biochemical analyzer. The results showed that FZQJ - containing serum remarkably inhibited proliferation of HepG2 cells in dose - and time - dependent manners, induced HepG2 cell apoptosis and caused a decrease of Δψ. Analysis of tumor tissue showed that FZQJ - induced apoptosis was accompanied by downregulation of Bcl-2 and upregulation of Bax, release of cytochrome c, activation of caspase 3 and 9, and cleavage of PARP. In addition, FZQJ increased the percentages of CD4(+) T and NK cells, the ratio of CD4(+) / CD8(+) T cells as well as the levels of serum TNF-α. FZQJ also increased CD69 expression in tumor tissue. No hepatorenal toxicity was observed in H22 tumor-bearing mice. These results indicated that FZQJ could inhibit the growth of hepatoma cells via regulating immune function and inducing mitochondria mediated apoptosis.
27335087	0	24	Fuzheng Qingjie Granules	T123	C0574031
27335087	25	32	Inhibit	T052	C3463820
27335087	33	39	Growth	T039	C0220844
27335087	43	57	Hepatoma Cells	T025	C0677626
27335087	62	70	Inducing	T169	C0205263
27335087	71	83	Mitochondria	T026	C0026237
27335087	94	103	Apoptosis	T043	C0162638
27335087	108	117	Enhancing	T052	C2349975
27335087	118	133	Immune Function	T042	C1817756
27335087	134	149	Fuzheng Qingjie	T123	C0574031
27335087	150	165	(FZQJ) granules	T123	C0574031
27335087	169	177	compound	T103	C1706082
27335087	178	194	Chinese medicine	T091	C0025123
27335087	217	233	adjuvant therapy	T061	C0677850
27335087	238	254	alimentary tract	T022	C0017189
27335087	255	262	cancers	T191	C0006826
27335087	288	298	anticancer	T033	C0243095
27335087	299	309	mechanisms	T169	C0441712
27335087	348	355	present	T079	C0521116
27335087	356	361	study	T062	C2603343
27335087	363	374	HepG2 cells	T025	C2717940
27335087	380	387	treated	T169	C1522326
27335087	393	397	FZQJ	T123	C0574031
27335087	400	410	containing	T052	C2700400
27335087	411	416	serum	T031	C0229671
27335087	418	436	Cell proliferation	T043	C0596290
27335087	441	450	evaluated	T058	C0220825
27335087	457	466	MTT assay	T062	C2986858
27335087	468	477	Apoptosis	T043	C0162638
27335087	482	490	analyzed	T062	C0936012
27335087	499	513	flow cytometer	T074	C0180279
27335087	515	534	Cell ultrastructure	T025	C3825563
27335087	539	547	observed	T169	C1441672
27335087	556	588	transmission electron microscope	T074	C0262880
27335087	594	626	mitochondrial membrane potential	T043	C1720920
27335087	628	630	Δψ	T043	C1720920
27335087	636	644	examined	T033	C0332128
27335087	650	658	JC-1 dye	T130	C0013343
27335087	663	685	H22 tumor-bearing mice	T191	C1512411
27335087	687	701	CD4(+) T cells	T025	C0039215
27335087	703	717	CD8(+) T cells	T025	C0242629
27335087	719	733	CD3(+) T cells	T025	C1267816
27335087	739	759	natural killer cells	T025	C0022688
27335087	761	763	NK	T025	C0022688
27335087	768	784	peripheral blood	T031	C0229664
27335087	800	814	cytometrically	T074	C0180279
27335087	816	834	Interleukin (IL)-2	T116,T129	C0021756
27335087	839	860	tumor necrosis factor	T116,T129	C0041368
27335087	861	868	(TNF)-α	T116,T129	C0041368
27335087	869	875	levels	T080	C0441889
27335087	881	889	measured	T080	C0444706
27335087	896	912	radioimmunoassay	T059	C0034580
27335087	918	922	mRNA	T114,T123	C0035696
27335087	923	929	levels	T080	C0441889
27335087	933	936	Bax	T028	C0812198
27335087	941	946	Bcl-2	T028	C0376515
27335087	952	960	examined	T033	C0332128
27335087	964	1011	reverse transcription-polymerase chain reaction	T063	C0599161
27335087	1017	1024	protein	T116,T123	C0033684
27335087	1025	1031	levels	T080	C0441889
27335087	1035	1038	Bax	T116,T123	C0219474
27335087	1040	1045	Bcl-2	T116,T123	C0210955
27335087	1047	1059	cytochrome C	T116,T126	C0010749
27335087	1061	1070	caspase 3	T116,T126	C0291573
27335087	1075	1076	9	T116,T126	C0910167
27335087	1078	1082	PARP	T116,T126	C0032405
27335087	1088	1092	CD69	T116,T129	C0108800
27335087	1098	1106	examined	T033	C0332128
27335087	1110	1126	Western blotting	T059,T063	C0005863
27335087	1132	1141	apoptotic	T080	C1516044
27335087	1142	1147	cells	T025	C0007634
27335087	1151	1158	tissues	T024	C0040300
27335087	1164	1172	observed	T169	C1441672
27335087	1179	1191	TUNEL method	T063	C0872284
27335087	1193	1213	Alanine transaminase	T116,T126	C0001899
27335087	1215	1218	ALT	T116,T126	C0001899
27335087	1221	1243	aspartate transaminase	T116,T126	C0004002
27335087	1245	1248	AST	T116,T126	C0004002
27335087	1251	1270	blood urea nitrogen	T123,T197	C0600137
27335087	1272	1275	BUN	T123,T197	C0600137
27335087	1282	1292	creatinine	T109,T123	C0010294
27335087	1294	1297	CRE	T109,T123	C0010294
27335087	1304	1312	detected	T033	C0442726
27335087	1319	1328	automatic	T169	C0205554
27335087	1329	1340	biochemical	T169	C0205474
27335087	1341	1349	analyzer	T074	C0179038
27335087	1355	1362	results	T169	C1274040
27335087	1375	1379	FZQJ	T123	C0574031
27335087	1382	1392	containing	T052	C2700400
27335087	1393	1398	serum	T031	C0229671
27335087	1410	1419	inhibited	T052	C3463820
27335087	1420	1433	proliferation	T043	C0596290
27335087	1437	1448	HepG2 cells	T025	C2717940
27335087	1452	1456	dose	T081	C1512045
27335087	1463	1467	time	T079	C0040223
27335087	1470	1479	dependent	T080	C0851827
27335087	1489	1496	induced	T169	C0205263
27335087	1497	1507	HepG2 cell	T025	C2717940
27335087	1508	1517	apoptosis	T043	C0162638
27335087	1531	1539	decrease	T081	C0547047
27335087	1543	1545	Δψ	T043	C1720920
27335087	1547	1555	Analysis	T062	C0936012
27335087	1559	1571	tumor tissue	T024	C0475358
27335087	1584	1588	FZQJ	T123	C0574031
27335087	1591	1598	induced	T169	C0205263
27335087	1599	1608	apoptosis	T043	C0162638
27335087	1628	1642	downregulation	T044	C0013081
27335087	1646	1651	Bcl-2	T116,T123	C0210955
27335087	1656	1668	upregulation	T044	C0041904
27335087	1672	1675	Bax	T116,T123	C0219474
27335087	1677	1684	release	T169	C1283071
27335087	1688	1700	cytochrome c	T116,T126	C0010749
27335087	1702	1712	activation	T044	C0014429
27335087	1716	1725	caspase 3	T116,T126	C0291573
27335087	1730	1731	9	T116,T126	C0910167
27335087	1737	1745	cleavage	T044	C0597304
27335087	1749	1753	PARP	T116,T126	C0032405
27335087	1768	1772	FZQJ	T123	C0574031
27335087	1773	1782	increased	T081	C0205217
27335087	1787	1798	percentages	T081	C0439165
27335087	1802	1810	CD4(+) T	T025	C0039215
27335087	1815	1823	NK cells	T025	C0022688
27335087	1829	1834	ratio	T081	C0456603
27335087	1838	1844	CD4(+)	T025	C0039215
27335087	1847	1861	CD8(+) T cells	T025	C0242629
27335087	1877	1883	levels	T080	C0441889
27335087	1887	1892	serum	T031	C0229671
27335087	1893	1898	TNF-α	T116,T129	C0041368
27335087	1900	1904	FZQJ	T123	C0574031
27335087	1910	1919	increased	T081	C0205217
27335087	1920	1924	CD69	T116,T129	C0108800
27335087	1925	1935	expression	T045	C1171362
27335087	1939	1951	tumor tissue	T024	C0475358
27335087	1953	1976	No hepatorenal toxicity	T033	C0243095
27335087	1981	1989	observed	T169	C1441672
27335087	1993	2015	H22 tumor-bearing mice	T191	C1512411
27335087	2023	2030	results	T169	C1274040
27335087	2031	2040	indicated	T033	C1444656
27335087	2046	2050	FZQJ	T123	C0574031
27335087	2057	2064	inhibit	T052	C3463820
27335087	2069	2075	growth	T039	C0220844
27335087	2079	2093	hepatoma cells	T025	C0677626
27335087	2109	2124	immune function	T042	C1817756
27335087	2129	2137	inducing	T169	C0205263
27335087	2138	2150	mitochondria	T026	C0026237
27335087	2160	2169	apoptosis	T043	C0162638